[Finished Printing? - Click Here to Return to Normal View]


NIDA Home > Publications > Research Monographs >    

Cost-Benefit/Cost-Effectiveness Research of Drug Abuse Prevention: Implications for Programming and Policy



NIDA Research Monograph, Number 176 [Printed in 1998]


If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.


To download all of the PDF documents in an archive format, choose the type you wish to download, decompress the file with the decompression software on your computer (the Win 3.1/95/98/NT version is self-extracting), then view using Adobe Acrobat Reader.

Macintosh - Monograph176.hqx (1 MB)
Windows 3.1/95/98/NT (self-extracting archive) - Monograph176.EXE (825 KB)



Click on link to go page

Table of Contents

Introduction-----1
William J. Bukoski

The Impact of Substance Abuse on Federal Spending-----5
Jeffrey Merrill and Kimberley Fox

A Historical Perspective on Effective Prevention-----37
Richard I. Evans

School-Based Approaches to Drug Abuse Prevention: Evidence for Effectiveness and Suggestions for Determining Cost-Effectiveness-----59
Gilbert J. Botvin, Elizabeth M. Botvin, and Hirsch Ruchlin

Effectiveness of Prevention Interventions With Youth at High Risk of Drug Abuse-----83
Richard F. Catalano, Kevin P. Haggerty, Randy R. Gainey, Marilyn J. Hoppe, and Devon D. Brewer

Costs, Benefits, and Cost-Effectiveness of Comprehensive Drug Abuse Prevention-----111
Mary Ann Pentz

Overview of Methods: Cost-Effectiveness, Cost-Benefits, and Cost-Offsets of Prevention-----130
Albert Woodward

Analytic Issues for Estimating the Benefits and Costs of Substance Abuse Prevention-----141
Gary A. Zarkin and Robert L. Hubbard

Benefits and Costs of a Family-Focused Methadone Treatment and Drug Abuse Prevention Program: Preliminary Findings-----161
Robert D. Plotnick, Diane S. Young, Richard F. Catalano, and Kevin P. Haggerty

Issues and Methods in Evaluating Costs, Benefits, and Cost-Effectiveness of Drug Abuse Prevention Programs for High-Risk Youth-----184
Marsha Lillie-Blanton, Lisa Werthamer, Pinka Chatterji, Claire Fienson, and Christine Caffray

Implications for Prevention Policy: A Commentary-----214
Robert L. DuPont

Ordering Information-----222



Advanced Search | FAQs | Accessibility | Site Map | Help | NIDA Home | Privacy Policy | FOIA (NIH) | Employment | Print Version
National Institutes of Health logo Department of Health and Human Services Logo

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 18, 2002.